CAR-T Referral Process: Insights from UCSF : Episode 7
Management of Adverse Events of Special Interest in Patients Receiving CAR -T-Cell Therapy for R/R Multiple Myeloma: Diarrhea, Guillain-Barrée Syndrome, Parkinson’s Disease, and Secondary Malignancies
Panelists discuss how challenges in the CAR T referral process include delayed referrals, patient logistics, and managing expectations. One institution addresses these through streamlined communication, patient education, and clear referral guidelines. Community physicians should refer early on, ensure candidacy, and collaborate closely to optimize outcomes.
- What are the most common challenges you have encountered in the CAR-TCAR T referral process, and how have you addressed them at your institution?
- What advice would you provide to community physicians regarding the appropriate timing and preparation for referring patients for CAR-TCAR T-cell therapy?
Recent Videos
Related Content
